Does Rallies show 13F holders for TDOC?

Yes. Rallies tracks hedge fund and 13F ownership data for TDOC, including fund names, share counts, latest tracked quarter, and position changes when available.

Is TDOC research on Rallies investment advice?

No. Rallies provides research, data, and educational context for TDOC. It does not provide personalized investment advice.

TDOC (Teladoc Health, Inc.) Stock Analysis - Hedge Fund Holdings

Teladoc Health, Inc. (TDOC) is a publicly traded Healthcare sector company. As of May 21, 2026, TDOC trades at $6.46 with a market cap of $1.15B and a P/E ratio of -5.64. TDOC moved -2.19% today. Year to date, TDOC is -10.99%; over the trailing twelve months it is -11.72%. Its 52-week range spans $4.40 to $15.21. Analyst consensus is buy with an average price target of $7.22. Rallies surfaces TDOC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns TDOC stock?

Hedge funds tracked by Rallies that own TDOC include Mangrove Partners, Maverick Capital, Pinebridge Investments, and Bridgewater Associates. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Teladoc Health, Inc..

TDOC Key Metrics

Key financial metrics for TDOC
Metric	Value
Price	$6.46
Market Cap	$1.15B
P/E Ratio	-5.64
EPS	$-1.14
Dividend Yield	0.00%
52-Week High	$15.21
52-Week Low	$4.40
Volume	919
Avg Volume	0
Revenue (TTM)	$2.53B
Net Income	$-200.32M
Gross Margin	0.00%

Top Hedge Funds Holding TDOC

Mangrove Partners holds 104.42K shares of TDOC, changed +10.11% as of Mar 31, 2026.
Maverick Capital holds 44.52K shares of TDOC, changed -21.93% as of Jun 30, 2024.
Pinebridge Investments holds 26.15K shares of TDOC, changed -77.88% as of Jun 30, 2024.
Bridgewater Associates holds 11.74K shares of TDOC, changed -98.15% as of Mar 31, 2026.

Latest TDOC News

Teladoc Health Q1: Integrated Care Up 2% to $395.4M, BetterHelp Down 9% — Apr 29, 2026
Hims Slumps 40% YTD to $20 After FDA Ban and Lower Q1 Guidance — Apr 10, 2026
Teladoc Health Shares Jump 4.4% After Deutsche Bank $11 Price Target Upgrade — Mar 10, 2026
Teladoc Q4 EPS Beats, Guides Q1 Sales Below Forecast; DB Sets $11 Target — Mar 10, 2026
Teladoc Health Upgraded to Buy with $11 Target on BetterHelp Turnaround — Mar 10, 2026

Recent TDOC Insider Trades

Catapano Joseph Ronald sold 675 (~$3.45K) on Apr 2, 2026.
DIVITA CHARLES III sold 27.73K (~$152.24K) on Mar 11, 2026.
Rodrigues Fernando M. sold 25.09K (~$124.98K) on Mar 3, 2026.

TDOC Analyst Consensus

22 analysts cover TDOC: 0 strong buy, 7 buy, 15 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $7.22.

Common questions about TDOC

Who owns TDOC stock?: Hedge funds tracked by Rallies that own TDOC include Mangrove Partners, Maverick Capital, Pinebridge Investments, and Bridgewater Associates. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Teladoc Health, Inc..
Does Rallies show 13F holders for TDOC?: Yes. Rallies tracks hedge fund and 13F ownership data for TDOC, including fund names, share counts, latest tracked quarter, and position changes when available.
Is TDOC research on Rallies investment advice?: No. Rallies provides research, data, and educational context for TDOC. It does not provide personalized investment advice.